512 related articles for article (PubMed ID: 11106679)
1. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
Correa P; Fontham ET; Bravo JC; Bravo LE; Ruiz B; Zarama G; Realpe JL; Malcom GT; Li D; Johnson WD; Mera R
J Natl Cancer Inst; 2000 Dec; 92(23):1881-8. PubMed ID: 11106679
[TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
[TBL] [Abstract][Full Text] [Related]
3. Preventing cancer by disrupting progression of precancerous lesions.
Blot WJ
J Natl Cancer Inst; 2000 Dec; 92(23):1868-9. PubMed ID: 11106670
[No Abstract] [Full Text] [Related]
4. Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
Gail MH; Brown LM; You WC
J Natl Cancer Inst; 2001 Apr; 93(7):559-60. PubMed ID: 11287457
[No Abstract] [Full Text] [Related]
5. Antioxidants, Helicobacter pylori and stomach cancer in Venezuela.
de Sanjosé S; Muñoz N; Sobala G; Vivas J; Peraza S; Cano E; Castro D; Sanchez V; Andrade O; Tompkins D; Schorah CJ; Axon AT; Benz M; Oliver W
Eur J Cancer Prev; 1996 Feb; 5(1):57-62. PubMed ID: 8664811
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
Plummer M; Vivas J; Lopez G; Bravo JC; Peraza S; Carillo E; Cano E; Castro D; Andrade O; Sánchez V; Garcia R; Buiatti E; Aebischer C; Franceschi S; Oliver W; Muñoz N
J Natl Cancer Inst; 2007 Jan; 99(2):137-46. PubMed ID: 17227997
[TBL] [Abstract][Full Text] [Related]
7. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
8. Does treatment of Helicobacter pylori infection reduce gastric precancerous lesions?
Mansour-Ghanaei F; Joukar F; Mojtahedi K; Sokhanvar H; Askari K; Shafaeizadeh A
Asian Pac J Cancer Prev; 2015; 16(4):1571-4. PubMed ID: 25743833
[TBL] [Abstract][Full Text] [Related]
9. KRAS mutations predict progression of preneoplastic gastric lesions.
Gong C; Mera R; Bravo JC; Ruiz B; Diaz-Escamilla R; Fontham ET; Correa P; Hunt JD
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):167-71. PubMed ID: 10067815
[TBL] [Abstract][Full Text] [Related]
10. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia.
Dixon MF
Gut; 2001 Jul; 49(1):2-4. PubMed ID: 11413099
[No Abstract] [Full Text] [Related]
11. Dynamics of
Mera RM; Bravo LE; Camargo MC; Bravo JC; Delgado AG; Romero-Gallo J; Yepez MC; Realpe JL; Schneider BG; Morgan DR; Peek RM; Correa P; Wilson KT; Piazuelo MB
Gut; 2018 Jul; 67(7):1239-1246. PubMed ID: 28647684
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.
Ito M; Haruma K; Kamada T; Mihara M; Kim S; Kitadai Y; Sumii M; Tanaka S; Yoshihara M; Chayama K
Aliment Pharmacol Ther; 2002 Aug; 16(8):1449-56. PubMed ID: 12182744
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group.
Varis K; Taylor PR; Sipponen P; Samloff IM; Heinonen OP; Albanes D; Härkönen M; Huttunen JK; Laxén F; Virtamo J
Scand J Gastroenterol; 1998 Mar; 33(3):294-300. PubMed ID: 9548624
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
15. Treatment of
Lahner E; Carabotti M; Annibale B
World J Gastroenterol; 2018 Jun; 24(22):2373-2380. PubMed ID: 29904244
[No Abstract] [Full Text] [Related]
16. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.
Massarrat S; Haj-Sheykholeslami A; Mohamadkhani A; Zendehdel N; Rakhshani N; Stolte M; Mirzaei M; Saliminejhad M; Saeidi S; Shahidi M
Arch Iran Med; 2012 Nov; 15(11):664-9. PubMed ID: 23102241
[TBL] [Abstract][Full Text] [Related]
17. [How to prevent precancerous gastric lesions].
Delchier JC
Gastroenterol Clin Biol; 2004 May; 28(5 Suppl):D172-7. PubMed ID: 15213677
[No Abstract] [Full Text] [Related]
18. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
[TBL] [Abstract][Full Text] [Related]
19. Review article: exploring the link between Helicobacter pylori and gastric cancer.
Kuipers EJ
Aliment Pharmacol Ther; 1999 Mar; 13 Suppl 1():3-11. PubMed ID: 10209681
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
